These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 19697028

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M, Minami M, Fujii K, Sendo R, Mori K, Shimizu D, Nakajima T, Yasui K, Itoh Y, Taniwaki M, Okanoue T, Yoshikawa T.
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
    Moses SE, Lim ZY, Sudhanva M, Devereux S, Ho AY, Pagliuca A, Zuckerman M, Mufti GJ.
    J Med Virol; 2006 Dec; 78(12):1560-3. PubMed ID: 17063522
    [Abstract] [Full Text] [Related]

  • 29. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE, Kim K, Lim TK, Park BB, Park S, Hong YS, Lee SC, Hwang IG, Koh KC, Lee MH, Ahn JS, Kim WS, Jung CW, Kang WK.
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
    Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, Chen CH.
    Ann Hematol; 2012 Jul; 91(7):1007-12. PubMed ID: 22273839
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
    Seto WK, Chan TS, Hwang YY, Wong DK, Fung J, Liu KS, Gill H, Lam YF, Lie AK, Lai CL, Kwong YL, Yuen MF.
    J Clin Oncol; 2014 Nov 20; 32(33):3736-43. PubMed ID: 25287829
    [Abstract] [Full Text] [Related]

  • 34. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    Zingarelli S, Frassi M, Bazzani C, Scarsi M, Puoti M, Airò P.
    J Rheumatol; 2009 Jun 20; 36(6):1188-94. PubMed ID: 19447932
    [Abstract] [Full Text] [Related]

  • 35. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct 20; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 36. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
    Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, Leung N, Luk JM, Lie AK, Kwong YL, Liang R, Lau GK.
    Gastroenterology; 2006 Jul 20; 131(1):59-68. PubMed ID: 16831590
    [Abstract] [Full Text] [Related]

  • 37. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK.
    Hepatology; 2002 Nov 20; 36(5):1246-52. PubMed ID: 12395336
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.
    Sarrecchia C, Cappelli A, Aiello P.
    J Infect Chemother; 2005 Aug 20; 11(4):189-91. PubMed ID: 16133710
    [Abstract] [Full Text] [Related]

  • 40. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 20; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.